Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (starpan/STAR-02 Study)

C. Pinto, F. Di Fabio, E. Maiello, S. Pini, T. Latiano, C. Aschele, C. Garufi, A. Bochicchio, G. Rosati, G. Aprile, S. Giaquinta, V. Torri, A. Bardelli, M. Gion, A. Martoni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (starpan/STAR-02 Study)'. Together they form a unique fingerprint.

Medicine & Life Sciences